208 related articles for article (PubMed ID: 17061961)
1. A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers.
Hindmarch I; Legangneux E; Stanley N; Emegbo S; Dawson J
Br J Clin Pharmacol; 2006 Nov; 62(5):538-45. PubMed ID: 17061961
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers.
Blin O; Micallef J; Audebert C; Legangneux E
J Clin Psychopharmacol; 2006 Jun; 26(3):284-9. PubMed ID: 16702893
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
4. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.
Otmani S; Demazières A; Staner C; Jacob N; Nir T; Zisapel N; Staner L
Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235
[TBL] [Abstract][Full Text] [Related]
5. Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers.
Farber RH; Burke PJ
Curr Med Res Opin; 2008 Mar; 24(3):837-46. PubMed ID: 18257978
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of zolpidem on daytime alertness, psychomotor and physical performance.
Ito SU; Kanbayashi T; Takemura T; Kondo H; Inomata S; Szilagyi G; Shimizu T; Nishino S
Neurosci Res; 2007 Nov; 59(3):309-13. PubMed ID: 17825448
[TBL] [Abstract][Full Text] [Related]
7. The acute effects of zolpidem, administered alone and with alcohol, on cognitive and psychomotor function.
Wilkinson CJ
J Clin Psychiatry; 1995 Jul; 56(7):309-18. PubMed ID: 7615484
[TBL] [Abstract][Full Text] [Related]
8. Next-day residual effects of gaboxadol and flurazepam administered at bedtime: a randomized double-blind study in healthy elderly subjects.
Boyle J; Wolford D; Gargano C; McCrea J; Cummings C; Cerchio K; Lines C
Hum Psychopharmacol; 2009 Jan; 24(1):61-71. PubMed ID: 18985628
[TBL] [Abstract][Full Text] [Related]
9. Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo.
Allain H; Bentué-Ferrer D; Tarral A; Gandon JM
Eur J Clin Pharmacol; 2003 Jul; 59(3):179-88. PubMed ID: 12756510
[TBL] [Abstract][Full Text] [Related]
10. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
Scharf MB; Roth T; Vogel GW; Walsh JK
J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
[TBL] [Abstract][Full Text] [Related]
11. Dose response effects of zolpidem in normal geriatric subjects.
Scharf MB; Mayleben DW; Kaffeman M; Krall R; Ochs R
J Clin Psychiatry; 1991 Feb; 52(2):77-83. PubMed ID: 1993640
[TBL] [Abstract][Full Text] [Related]
12. Cognitive performance following premature awakening from zolpidem or melatonin induced daytime sleep.
Storm WF; Eddy DR; Welch CB; Hickey PA; Fischer J; Cardenas R
Aviat Space Environ Med; 2007 Jan; 78(1):10-20. PubMed ID: 17225476
[TBL] [Abstract][Full Text] [Related]
13. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem.
Leufkens TR; Lund JS; Vermeeren A
J Sleep Res; 2009 Dec; 18(4):387-96. PubMed ID: 19552733
[TBL] [Abstract][Full Text] [Related]
14. Residual effects of zolpidem, triazolam, rilmazafone and placebo in healthy elderly subjects: a randomized double-blind study.
Uemura SI; Kanbayashi T; Wakasa M; Satake M; Ito W; Shimizu K; Shioya T; Shimizu T; Nishino S
Sleep Med; 2015 Nov; 16(11):1395-1402. PubMed ID: 26498242
[TBL] [Abstract][Full Text] [Related]
15. Effects of bretazenil vs. zolpidem and placebo on experimentally induced sleep disturbance in healthy volunteers.
Gieschke R; Cluydts R; Dingemanse J; De Roeck J; De Cock W
Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):667-75. PubMed ID: 7746029
[TBL] [Abstract][Full Text] [Related]
16. The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study.
Moldofsky H; Lue FA; Mously C; Roth-Schechter B; Reynolds WJ
J Rheumatol; 1996 Mar; 23(3):529-33. PubMed ID: 8832997
[TBL] [Abstract][Full Text] [Related]
17. The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers.
Fairweather DB; Kerr JS; Hindmarch I
Eur J Clin Pharmacol; 1992; 43(6):597-601. PubMed ID: 1493840
[TBL] [Abstract][Full Text] [Related]
18. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.
Verster JC; Volkerts ER; Schreuder AH; Eijken EJ; van Heuckelum JH; Veldhuijzen DS; Verbaten MN; Paty I; Darwish M; Danjou P; Patat A
J Clin Psychopharmacol; 2002 Dec; 22(6):576-83. PubMed ID: 12454557
[TBL] [Abstract][Full Text] [Related]
19. Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone.
Boyle J; Trick L; Johnsen S; Roach J; Rubens R
Hum Psychopharmacol; 2008 Jul; 23(5):385-97. PubMed ID: 18350566
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
Walsh JK; Soubrane C; Roth T
Am J Geriatr Psychiatry; 2008 Jan; 16(1):44-57. PubMed ID: 18165461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
